Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method.

Salem ESB, Murakami K, Takahashi T, Bernhard E, Borra V, Bethi M, Nakamura T.

J Vis Exp. 2018 Oct 23;(140). doi: 10.3791/58323.

PMID:
30417869
2.

Hepatic Ago2-mediated RNA silencing controls energy metabolism linked to AMPK activation and obesity-associated pathophysiology.

Zhang C, Seo J, Murakami K, Salem ESB, Bernhard E, Borra VJ, Choi K, Yuan CL, Chan CC, Chen X, Huang T, Weirauch MT, Divanovic S, Qi NR, Thomas HE, Mercer CA, Siomi H, Nakamura T.

Nat Commun. 2018 Sep 10;9(1):3658. doi: 10.1038/s41467-018-05870-6.

3.

Antiobesity Action of ACAM by Modulating the Dynamics of Cell Adhesion and Actin Polymerization in Adipocytes.

Murakami K, Eguchi J, Hida K, Nakatsuka A, Katayama A, Sakurai M, Choshi H, Furutani M, Ogawa D, Takei K, Otsuka F, Wada J.

Diabetes. 2016 May;65(5):1255-67. doi: 10.2337/db15-1304. Epub 2016 Mar 8.

4.

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Nakatsuka A, Matsuyama M, Yamaguchi S, Katayama A, Eguchi J, Murakami K, Teshigawara S, Ogawa D, Wada N, Yasunaka T, Ikeda F, Takaki A, Watanabe E, Wada J.

Sci Rep. 2016 Feb 17;6:21721. doi: 10.1038/srep21721.

5.

Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis.

Katayama A, Nakatsuka A, Eguchi J, Murakami K, Teshigawara S, Kanzaki M, Nunoue T, Hida K, Wada N, Yasunaka T, Ikeda F, Takaki A, Yamamoto K, Kiyonari H, Makino H, Wada J.

Sci Rep. 2015 Nov 19;5:16920. doi: 10.1038/srep16920.

6.

Complication of chronic eosinophilic pneumonia in an elderly patient with Sjögren syndrome.

Waseda K, Hagiya H, Hanayama Y, Terasaka T, Kimura K, Tsuzuki T, Hasegawa K, Nada T, Nakamura E, Murakami K, Kondo E, Otsuka F.

Acta Med Okayama. 2015;69(2):123-7.

7.

Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes.

Wang Y, Katayama A, Terami T, Han X, Nunoue T, Zhang D, Teshigawara S, Eguchi J, Nakatsuka A, Murakami K, Ogawa D, Furuta Y, Makino H, Wada J.

Metabolism. 2015 Jun;64(6):677-88. doi: 10.1016/j.metabol.2015.02.004. Epub 2015 Feb 23.

PMID:
25749183
8.

Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.

Higuchi C, Nakatsuka A, Eguchi J, Teshigawara S, Kanzaki M, Katayama A, Yamaguchi S, Takahashi N, Murakami K, Ogawa D, Sasaki S, Makino H, Wada J.

Metabolism. 2015 Apr;64(4):489-97. doi: 10.1016/j.metabol.2014.12.003. Epub 2014 Dec 18.

PMID:
25726255
9.

Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy.

Watanabe M, Nakatsuka A, Murakami K, Inoue K, Terami T, Higuchi C, Katayama A, Teshigawara S, Eguchi J, Ogawa D, Watanabe E, Wada J, Makino H.

PLoS One. 2014 Mar 25;9(3):e92647. doi: 10.1371/journal.pone.0092647. eCollection 2014.

10.

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes.

Terami T, Wada J, Inoue K, Nakatsuka A, Ogawa D, Teshigawara S, Murakami K, Katayama A, Eguchi J, Makino H.

Int J Nephrol Renovasc Dis. 2013 Oct 22;6:233-40. doi: 10.2147/IJNRD.S51829. eCollection 2013.

11.

Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.

Inoue K, Wada J, Eguchi J, Nakatsuka A, Teshigawara S, Murakami K, Ogawa D, Terami T, Katayama A, Tone A, Iseda I, Hida K, Yamada M, Ogawa T, Makino H.

PLoS One. 2013 Oct 15;8(10):e77118. doi: 10.1371/journal.pone.0077118. eCollection 2013.

12.

Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease.

Kurose Y, Wada J, Kanzaki M, Teshigawara S, Nakatsuka A, Murakami K, Inoue K, Terami T, Katayama A, Watanabe M, Higuchi C, Eguchi J, Miyatake N, Makino H.

BMC Nephrol. 2013 Jan 22;14:23. doi: 10.1186/1471-2369-14-23.

13.

Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex.

Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H.

Circ Res. 2013 Mar 1;112(5):771-80. doi: 10.1161/CIRCRESAHA.111.300049. Epub 2013 Jan 10. Erratum in: Circ Res. 2013 Apr 26;112(9):e98.

PMID:
23307819
14.

Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex.

Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Horiguchi CS, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H.

Diabetes. 2012 Nov;61(11):2823-32. doi: 10.2337/db12-0232. Epub 2012 Jul 26.

15.

The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).

Murakami K, Wada J, Ogawa D, Horiguchi CS, Miyoshi T, Sasaki M, Uchida HA, Nakamura Y, Makino H.

Diab Vasc Dis Res. 2013 Jan;10(1):93-6. doi: 10.1177/1479164112444640. Epub 2012 May 4. Erratum in: Diab Vasc Dis Res. 2013 Nov;10(6):554.

PMID:
22561230
16.

Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population.

Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Iseda I, Matsushita Y, Miyatake N, McDonald JF, Hotta K, Makino H.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1202-7. doi: 10.1210/jc.2011-3297. Epub 2012 Apr 26.

PMID:
22539588
17.

Weber-Christian disease developing into mediastinitis and pleuritis with massive pleural effusion.

Hirasaki S, Murakami K, Kanamori T, Mizushima T, Hanayama Y, Koide N.

Intern Med. 2012;51(8):943-7. Epub 2012 Apr 15. Review.

18.

A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins.

Kanzaki M, Wada J, Nakatsuka A, Teshigawara S, Murakami K, Inoue K, Terami T, Katayama A, Nasu J, Yamamoto K, Makino H.

Intern Med. 2012;51(6):619-23. Epub 2012 Mar 15.

19.

Successful treatment of sepsis caused by Staphylococcus lugdunensis in an adult with 22q11.2 deletion syndrome.

Hirasaki S, Murakami K, Mizushima T, Ohmori K, Fujita S, Hanayama Y, Kanamori T, Yokota R, Ebara H, Kusano N, Kudo C, Yamaguchi T, Akagi T, Koide N.

Intern Med. 2012;51(4):377-80. Epub 2012 Feb 15.

20.

Long-term Taenia saginata infection successfully treated with meglumine/diatrizoate sodium.

Hirasaki S, Murakami K, Mizushima T, Hiramatsu K, Hanayama Y, Kanamori T, Koide N.

Intern Med. 2012;51(2):177-9. Epub 2012 Jan 15.

Supplemental Content

Loading ...
Support Center